Sign in

NCT06013007Completed

Joint Inflation With Nominal-pressure and Stability Approach in DES Optimization

Joint Inflation With Nominal-pressure and Stability Approach in Coronary Drug-Eluting Stent Optimization and Outcomes

Source: ClinicalTrials.gov · Last updated 9 Mar 2026

Brief summary (registry, in English)

To achieve the stent optimization following "Keep It Simple and Safe" coronary intervention is recommended. A protocol of Joint Inflation with Nominal-pressure and Stability (JINS) approach in coronary drug-eluting stent (DES) implantation by intracoronary imaging (ICI) guidance could provide additional benefits in reducing unnecessary radiation exposure, and post-dilatation balloon angioplasty-related complications.

Status (registry)
Completed
Study type
Interventional
Enrollment
161 (actual)
First submitted
21 Aug 2023
Start date
22 Aug 2023
Primary completion date
5 Mar 2026
Lead sponsor
Zunyi Medical College
NCT number
NCT06013007

What you commit to

  • Study type: Interventional
  • Participants enrolled: 161
  • From 22 Aug 2023 to the primary completion date, 5 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Lab values

  • Active bleeding or bleeding diathesis, thrombocytopenia (platelet \<100,000/mL), or hemoglobin \<10 g/dL
  • Hepatic dysfunction (serum liver enzyme\>3 times the normal limit)
  • Renal failure (eGFR \<15 ml/min/1.73m2 or requiring dialysis)

Other

  • Left main, ostial right coronary artery lesion.
  • High thrombus burden at the index primary percutaneous coronary intervention.
  • Life expectancy \< 1 year

Who the study is looking for

  • Patients with acute coronary syndrome (UA/NSTEMI/STEMI) plan to undergo OCT- or IVUS-guided DES implantation in de novo lesion.
  • Patients provide written informed consent prior to enrollment.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Affiliated Hospital of Zunyi Medical University
Coordinator of this site? Confirm its status
ZunyiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.